Neuropsychology for movement disorders neurosurgery

Canadian Journal of Neurological Sciences

Volumn 30, Issue SUPPL. 1, 2003, Pages

  Saint Cyr, Jean A ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN CORTEX; BRAIN DEPTH STIMULATION; COGNITION; COST BENEFIT ANALYSIS; DEMENTIA; DEPRESSION; DIFFERENTIAL DIAGNOSIS; FAMILY; FEEDBACK SYSTEM; HUMAN; MOTOR DYSFUNCTION; NERVE CELL PLASTICITY; NEUROPSYCHOLOGY; NEUROSURGERY; PATIENT COUNSELING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SCREENING; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0037352156     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100003280     Document Type: Review

References (190)

1. Paulsen JS, Zhao H, Stout JC, et al. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 2001; 57(4): 658-662.
2. Albin RL, Aldridge JW, Young AB, Gilman S. Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity. Brain Res 1989; 491(1): 185-188.
3. Wichmann T, DeLong MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996; 6(6): 751-758.
4. Lang AE, Lozano AM. Parkinson's disease - first of two parts. N Eng J Med 1998a; 339(15): 1044-1053.
5. Schultz W, Tremblay L, Hollerman JR. Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 1998; 37: 421-429.
6. Gotham AM, Brown RG, Marsden CD. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 1988; 111(2): 299-321.
7. Pullman SL, Watts RL, Juncos JL, et al. Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease. Neurology 1988; 38(2): 249-254.
8. Lange KW, Robbins TW, Marsden CD, et al. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 1992; 107(2-3): 394-404.
9. Malapani C, Pillon B, Dubois B, Agid Y. Impaired simultaneous cognitive task performance in Parkinson's disease: a dopaminerelated dysfunction. Neurology 1994; 44(2): 319-326.
10. Owen A, Sahakian B, Hodges J, et al. Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease. Neuropsychology 1995; 9(1): 126-140.
11. Kulisevsky J, Avila A, Barbanoj M, et al. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels. Brain 1996; 119(6): 2121-2132.
12. Malapani C, Rakitin B, Levy R, et al. Coupled temporal memories in Parkinson's disease: a dopamine-related dysfunction. J Cog Neuroscience 1998; 10(3): 316-331.
13. Starr PA, Vitek JL, Bakay RAE. Deep brain stimulation for movement disorders. Neurosurg Clin N Am 1998a; 9: 381-402.
14. Lozano AM, (Ed). Movement Disorder Surgery. Basel: Kargar, 2000.
15. Louw DF, Burchiel KJ. Ablative therapy for movement disorders. Complications in the treatment of movement disorders. Neurosurg Clin N Am 1998; 9: 367-373.
16. Wilkinson SB, Tröster AI. Surgical interventions in neurodegenerative disease: impact on memory and cognition. In: Tröster AI, (Ed). Memory in Neurodegenerative Disease: Biological, Cognitive, and Clinical Perspectives. Cambridge, UK: Cambridge University Press, 1998: 362-376.
17. Divac I. Neostriatum and functions of the prefrontal cortex. Acta Neurobiol Exp (Warsaw) 1972; 32: 461-477.
18. Rosvold E. The frontal lobe system: cortical-subcortical relationships. Acta Neurobiol Exp (Warsaw) 1972; 32: 439-460.
19. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994; 117: 859-876.
20. Dubois B, Defontaines B, Deweer B, Malapani C, Pillon B. Cognitive and behavioral changes in patients with focal lesions of the basal ganglia. Adv Neurol 1995; 65: 29-42.
21. McFie J. Psychological effects of stereotaxic operations for the relief of parkinsonian symptoms. J Mental Science 1960; 166: 1512-1517.
22. Ricklan M, Diller L, Weiner H, et al. Psychological studies on effects of chemosurgery of the basal ganglia in parkinsonism. I. Intellectual functioning. AMA Arch Gen Psychiatry 1960a; 2: 32/22-42/32.
23. Ricklan M, Diller L, Weiner, H. Psychological studies on effects of chemosurgery of the basal ganglia in parkinsonism. II. Aspects of personality. AMA Arch Gen Psychiatry, 1960b; 2: 71/267-79/275.
24. Kocher U, Siegfried J, Perret E. Verbal and nonverbal learning ability of Parkinson patients before and after unilateral ventrolateral thalamotomy. App Neurophysiol 1982; 45: 311-316.
25. Guridi J, Lozano AM. A brief history of pallidotomy. Neurosurgery 1998; 41: 1169-1183.
26. Parkinson J. An Essay on the Shaking Palsy. London: Sherwood, Neely and Jones, 1817.
27. Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson's disease: the cortical focus of neostriatal outflow. Brain 1986; 109(5): 845-883.
28. Taylor AE, Saint-Cyr JA, Lang AE. Parkinson's disease. Cognitive changes in relation to treatment response. Brain 1987; 110(1): 35-51.
29. Saint-Cyr JA, Taylor AE, Lang AE. Procedural learning and neostriatal dysfunction in man. Brain 1988; 111(4): 941-959.
30. Taylor AE, Saint-Cyr JA, Lang AE. Memory and learning in early Parkinson's disease: evidence for a "frontal lobe syndrome". Brain Cog 1990; 13: 211-232.
31. Dubois B, Boller F, Pillon B, Agid Y. Cognitive deficits in Parkinson's disease. In: Corkin S, Boller F, Grafman J, (Eds). Handbook of Neuropsychology Vol 5. Amsterdam: Elsevier, 1991: 195-240.
32. Owen AM, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992; 115: 1727-1751.
33. Elsinger PJ, Grattan LM. Frontal lobe and frontal-striatal substrates for different forms of human cognitive flexibility. Neuropsychologia 1993; 31: 17-28.
34. Saint-Cyr JA, Taylor AE, Nicholson K. Behavior and the basal ganglia. Adv Neurol 1995; 65: 1-28.
35. Owen AM, Doyon J, Dagher A, et al. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 1998; 121: 949-965.
36. Rogers RD, Sahakian BJ, Hodges JR, et al. Dissociating executive mechanisms of task control following frontal lobe damage and Parkinson's disease. Brain 1998; 121: 815-842.
37. Troster AI, Woods SP. Neuropsychological Aspects of Parkinson's Disease and Parkinsonian Syndromes. In: Pahwa R, Lyons KE, Koller WC, (Eds). Handbook of Parkinson's Disease. (3rd ed.) New York: Marcel Dekker, 2003, in press.
38. Alexander GE, Crutcher MD, DeLong MR. Basal gangliathalamo-cortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. In: Progress in Brain Research, Vol. 85. Amsterdam: Elsevier, 1990: 19-146.
39. Brown RG, Marsden CD. Cognitive function in Parkinson's disease: from description to theory. Trends Neurosci 1990; 13(1): 21-29.
40. Saint-Cyr JA, Taylor AE, Trépanier LL, Lang AE. The caudate nucleus: head ganglion of the habit system. In: Vallar G, Cappa SF, Wallesch CW, (Eds). Neuropsychological disorders associated with subcortical lesions. Oxford: Oxford Science Publications, 1992: 204-226.
41. Saint-Cyr JA, Taylor AE. The mobilization of procedural learning. The "key signature" of the basal ganglia. In: Butters N, Squire LR, (Eds). Neuropsychology of Memory (2nd ed). New York: The Guilford Press, 1992: 188-202.
42. Dubois B, Pillon B. Cognitive deficits in Parkinson's disease. J Neurol 1997; 244: 2-8.
43. Knoke D, Taylor A, Saint-Cyr J. The differential effects of cueing on recall in Parkinson's disease and normal subjects. Brain Cogn 1998; 38: 261-274.
44. West R, Ergis AM, Winocur G, Saint-Cyr J. The contribution of impaired working memory monitoring to performance of the self-ordered pointing task in normal aging and Parkinson's disease. Neuropsychology 1998; 12: 546-554.
45. Owen AM, Doyon J. The cognitive neuropsychology of Parkinson's disease: a functional neuroimaging perspective. In: Stern GM, (Ed). Parkinson's Disease: Advances in Neurology (Vol. 80). Philadelphia: Lippincott, Williams & Wilkins; 1999: 49-56.
46. Saint-Cyr JA. Frontal-striatal circuit functions: context, sequence and consequence. J Int Neuropsych Soc. In press.
47. Saint-Cyr JA, Trépanier LL. Neuropsychologic assessment of patients for movement disorder surgery. Mov Disord 2000; 15(5): 771-783.
48. Lang AE, Lozano AM. Parkinson's disease - second of two parts. N Eng J Med 1998b; 339(16): 1130-1143.
49. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999; 14(4): 572-584.
50. Lang AE, Widner H. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Mov Disord 2002; 17(Supp 13): S94-S101.
51. Krack P, Pollak P, Limousin P, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998; 121(3): 451-457.
52. Benabid AL, Krack PP, Benazzouz A, et al. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology 2000; 55(12 Suppl 6): S40-S44.
53. Lang AE, Lozano AM, Montgomery E, et al. Posteroventral medial pallidotomy in advanced Parkinson's disease. New Eng J Med 1997; 337(15): 1036-1042.
54. Dymek M, Marson D, Atchison P. Executive dysfunction and capacity to consent to treatment in Parkinson's disease. Arch Clin Neuropsych 1999; 14: 48.
55. Jahanshahi M, Brown RG, Rothwell JC, et al. Subthalamic nucleus (STN) and globus pallidus (GPi) stimulation in Parkinson's disease: - I. Effects on executive function and working memory. Mov Disord 1997; 12 (Suppl 1): 130.
56. Stebbins GT, Gabrieli JD, Masciara F, Goetz CG. Cognitive processing speed affects both working memory and strategic memory in PD and normal aging. Mov Disord 1997; 12: 128.
57. Saint-Cyr JA, Trépanier LL, Kumar R, et al. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000; 123: 101-118.
58. Peavy GM, Salmon D, Bear PI, et al. Detection of mild cognitive deficits in Parkinson's disease patients with the WAIS-R NI. J Int Neuropsychol Soc 2001; 7(5): 535-543.
59. Tröster AI, Fields JA. The role of neuropsychological evaluation in the neurosurgical treatment of movement disorders. In: Tarsy D, Vitek JL, Lozano AM, (Eds). Surgical Treatment of Parkinson's Disease and Other Movement Disorders. Totowa, NJ: Humana Press. 2003;213:240.
60. Huber S, Christy J, Paulson G. Cognitive heterogeneity associated with clinical subtypes of Parkinson's disease. Neuropsychiatry Neuropsychol Behav Neurol 1991; 4: 147-157.
61. Filoteo JV, Rilling LM, Cole B, et al. Variable memory profiles in Parkinson's disease. J Clin Exp Neuropsychol 1997; 19: 878-888.
62. Graham J, Sagar H. A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes. Mov Disord 1999; 14: 10-20.
63. Stocchi F, Brusa L. Cognition and emotion in different stages and subtypes of Parkinson's disease. J Neurol 2000; 247(Suppl 2): II114-II121.
64. Gwinn-Hardy K. Genetics of parkinsonism. Mov Disord 2002; 17(4): 645-656.
65. Rajput AH. Frequency and cause of Parkinson's Disease. Can J Neurol Sci 1992a; 19: 103-107.
66. Scott R, Gregory R, Hines N, et al. Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures. Brain 1998; 121(4): 659-675.
67. Trépanier LL, Saint-Cyr JA, Lozano AM, Lang AE. Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease. Neurology 1998; 51(1): 207-215.
68. Lang A, Duff J, Saint-Cyr J, et al. Posteroventral medial pallidotomy in Parkinson's disease. J Neurol 1999; 246 (Suppl 2): II28-II41.
69. Trépanier L, Kumar R, Lozano A, et al. Neuropsychological outcome of neurosurgical therapies in Parkinson's disease: a comparison of GPi pallidotomy and deep brain stimulation of GPi or STN. Brain Cog 2000; 42(3): 324-347.
70. Aarsland D, Tandberg E, Larsen JP, et al. Frequency of dementia in Parkinson disease. Arch Neurol 1996; 53: 538-542.
71. Aarsland D, Ballard C, McKeith I, Perry RH, Larsen JP. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001; 13(3): 374-379.
72. Mayeux R, Chen J, Mirabello E, et al. An estimate of the incidence of dementia in idiopathic Parkinson's disease. Neurology 1990; 40: 1513-1517.
73. Jefferson AL, Cosentino SA, Ball SK, et al. Errors produced on the mini-mental state examination and neuropsychological test performance in Alzheimer's disease, ischemic vascular dementia, and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2002; 14(3): 311-320.
74. Mahieux F, Michelet D, Manifacier M-J, et al. Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease. Behav Neurol 1995; 8: 15-22.
75. Mattis S. Dementia Rating Scale: Professional manual. Odessa, Florida: Psychological Assessment Resources, 1988.
76. Chui HC, Perlmutter LS. Pathological correlates of dementia in Parkinson's disease. In: Huber SJ, Cummings JL, (Eds). Parkinson's Disease: Neurobehavioral Aspects. New York: Oxford University Press, 1992: 164-177.
77. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124.
78. Pasquier F, Delacourte A. Non-Alzheimer degenerative dementias. Curr Opin Neurol 1998; 11: 417-427.
79. McKeith IG, Burn D. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. Neurol Clin 2000; 18: 865-902.
80. Tedeschi G, Litvan I, Bonavita S, et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal ganglionic degeneration. Brain 1997; 120: 1541-1552.
81. 18F] fluorodeoxyglucose and PET. Mov Disord 1998; 13: 268-274.
82. Summerfield C, Gomez-Anson B, Tolosa E, et al. Dementia in Parkinson disease: a proton magnetic resonance spectroscopy study. Arch Neurol 2002; 59(9): 1415-1420.
83. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140-148.
84. Apaydin H, Ahlskog JE, Parisi JE, et al. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 2002; 59(1): 102-112.
85. Levy G, Schupf N, Tang MX, et al. Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 2002; 51(6): 722-729.
86. Rajput AH. Prevalence of dementia in Parkinson's disease. In: Huber SJ, Cummings JL, (Eds). Parkinson's Disease: Neurobehavioral Aspects. New York: Oxford University Press, 1992b: 119-131.
87. Absher JR, Cummings JL. Noncognitive behavioral alterations in dementia syndromes. In: Spinnler H, Boller F, (Eds). Handbook of Neuropsychology. New York: Elsevier, 1993: 315-338.
88. Dalla Barba G, Boller F. Non-Alzheimer degenerative dementias. Curr Opin Neurol 1994; 7(4): 305-309.
89. Jacobs DM, Marder K, Côté LJ, et al. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology 1995; 45: 1691-1696.
90. Lieberman AP, Trojanowski JQ, Lee VM, et al. Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease. Ann Neurol 1998; 43: 259-265.
91. Papka M, Rubio A, Schiffer RB. A review of Lewy body disease, an emerging concept of cortical dementia. J Neuropsychiatry Clin Neurosci 1998; 10: 267-279.
92. Saint-Cyr JA, Taylor AE, Lang AE. Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease. Neurology 1993; 43: S47-S52.
93. Vazquez A, Sempere AP, Duarte J, et al. Psychiatric manifestations and their predictive risk factors in Parkinson disease (Survey of a cohort of 520 patients). Mov Disord 1997; 12: 128.
94. Vingerhoets G, van der Linden C, Lannoo E, et al. Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 66: 297-304.
95. Shergill SS, Walker Z, Le Katona C. A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis. J Neurol Neurosurg Psychiatry 1998; 65: 610-611.
96. Brown RG, MacCarthy B. Psychiatric morbidity in patients with Parkinson's disease. Psychol Med 1990; 20(1): 77-87.
97. Menza MA, Robertson-Hoffman DE, Bonapace AS. Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry 1993; 34: 465-470.
98. Meara J, Hobson P. Depression, anxiety and hallucinations in Parkinson's disease. Elder Care 1998; 10: S4-S5.
99. Wolters EC. Dopaminomimetic psychosis in Parkinson's disease patients. Neurology 1999;52 (Suppl 3):S10-S13.
100. Cummings J. Depression and Parkinson's disease: a review. Am J Psychiatry 1992;149:443-454.
101. Poewe W, Luginger E. Depression in Parkinson's disease: impediments to recognition and treatment options. Neurology 1999;52 (Suppl 3):S2-S6.
102. Edwards E, Kitt C, Oliver E, et al. Depression and Parkinson's disease: a new look at an old problem. Depress Anxiety 2002; 16(1): 39-48.
103. Starkstein SE, Mayberg HS, Leiguarda R, et al. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992; 55: 377-382.
104. Cole SA, Woodard JL, Juncos JL, et al. Depression and disability in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1996; 8: 20-25.
105. Shulman LM. Apathy in patients with Parkinson's disease. Int Rev Psychiatry 2000; 12: 298-306.
106. Fields JA, Norman S, Straits-Tröster KA, Tröster AI. The impact of depression on memory in neurodegenerative disease. In: Tröster AI, (Ed). Memory in Neurodegenerative Disease: Biological, Cognitive, and Clinical Perspectives. New York: Cambridge University Press, 1998: 314-337.
107. Taylor AE, Saint-Cyr JA. Depression in Parkinson's disease: reconciling physiological and psychological perspectives. J Neuropsychiatry Clin Neurosci 1990; 2(1): 92-98.
108. Starkstein SE, Bolduc PL, Mayberg HS, Preziosi TJ, Robinson RG. Cognitive impairments and depression in Parkinson's disease: a follow up study. J Neurol Neurosurg Psychiatry 1990;53:597-602.
109. Tröster AI, Stalp LD, Paolo AM, et al. Neuropsychological impairment in Parkinson's disease with and without depression. Arch Neurol 1995; 52: 1164-1169.
110. Kuzis G, Sabe L, Tiberti C, et al. Cognitive functions in major depression and Parkinson disease. Arch Neurol 1997; 54: 982-986.
111. Norman S, Tröster AL, Fields JA, Brooks R. Effects of depression and Parkinson's disease on cognitive functioning. J Neuropsych Clin Neurosci 2002; 14: 31-36.
112. Starkstein S, Leiguardia R, Gershan O, et al. Neurosurgical disturbance in hemiparkinson's disease. Neurology 1987; 37: 1762-1764.
113. Fahim S, van Duijn CM, Baker FM, et al. A study of familial aggregation of depression, dementia and Parkinson's disease. Eur J Epidemiol 1998; 14: 233-238.
114. Heberlein I, Ludin HP, Scholz J, Vieregge P. Personality, depression, and premorbid lifestyle in twin pairs discordant for Parkinson's disease. J Neurol Neurosurg Psychiatry 1998;64: 262-266.
115. Sano M, Stern Y, Côté L, et al. Depression in Parkinson's disease: a biochemical model. J Neuropsychiatry Clin Neurosci 1990; 2: 88-92.
116. Mayberg HS, Solomon DH. Depression in Parkinson's disease: a biochemical and organic viewpoint. Adv Neurol 1995; 65: 49-60.
117. Stojanovic M, Filipovic SR, Kacar A, et al. Obsessive-compulsive symptoms in Parkinson's disease. Mov Disord 1997; 12: 128.
118. Glosser G, Clark C, Freundlich B, et al. A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Mov Disord 1995; 10: 201-206.
119. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 1994; 6(4): 358-370.
120. Côté L. Depression: Impact and management by the patient and family. Neurology 1999; 52(Suppl 3): S7-S9.
121. Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72(6): 701-707.
122. Kazumata K, Antonini A, Dhawan V, et al. Preoperative indicators of clinical outcome following stereotaxic pallidotomy. Neurology 1997; 49: 1083-1090.
123. Samuel M, Caputo E, Brooks DJ, et al. A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications. Brain 1998; 121: 59-75.
124. Scott RB. Cognitive function and pallidotomy. J Neurol Neurosurg Psychiatry 1998; 65(2): 148.
125. York MK, Levin HS, Grossman RG, et al. Neuropsychological outcome following unilateral pallidotomy. Brain 1999; 122: 2209-2220.
126. Green J, Barnhart H. The impact of lesion laterality on neuropsychological change following posterior pallidotomy: a review of current findings. Brain Cog 2000; 42(3): 379-398.
127. Stebbins GT, Gabrieli JDE, Shannon KM, et al. Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease. Brain Cog 2000; 42(3): 348-363.
128. De Bie RM, De Haan RJ, Schuurman PR, et al. Morbidity and mortality following pallidotomy in Parkinson's disease: a systematic review. Neurology 2002; 58: 1008-1012.
129. Green J, McDonald WM, Vitek JL, et al. Neuropsychological and psychiatric sequelae of pallidotomy for PD: clinical trial findings. Neurology 2002;58(6):858-865.
130. Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of the effects of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998a; 51(3): 850-855.
131. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995; 346: 1383-1387.
132. Perozzo P, Rizzone M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: comparison of pre- and postoperative neuropsychological evaluation. J Neurol Sci 2001; 192(1-2): 9-15.
133. Wilson S, Bladin P, Saling M. The "burden of normality": concepts of adjustment after surgery for seizures. J Neurol Neurosurg Psychiatry 2001; 70(5): 649-656.
134. Shannon KM, Penn RD, Kroin JS, et al. Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients. Neurology 1998; 50: 434-438.
135. Ghika J, Ghika-Schmid F, Fankhauser H, et al. Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature. J Neurosurg 1999; 91(2): 313-321.
136. Scott RB, Harrison J, Boulton C, et al. Global attentional-executive sequelae following surgical lesions to globus pallidus interna. Brain 2002; 125(Pt 3): 562-574.
137. Turner KR, Reid WG, Homewood J, et al. Neuropsychological sequelae of bilateral posteroventral pallidotomy. J Neurol Neurosurg Psychiatry 2002; 73(4): 444-446.
138. Crowe SF, O'Sullivan JD, Peppard RF, et al. Left posteroventral pallidotomy results in a deficit in verbal memory. Behav Neurol 1998; 11: 79-84.
139. Uitti RJ, Wharen RE, Jr Turk MF, et al. Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Neurology 1997; 49: 1072-1077.
140. Masterman D, DeSalles A, Baloh RW, et al. Motor, cognitive, and behavioral performance following unilateral posterior pallidotomy for Parkinson's disease. Arch Neurol 1998; 55: 1201-1208.
141. Tröster AI, Fields JA, Wilkinson SB, et al. Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation. Neurology 1997; 49: 1078-1083.
142. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994; 117: 877-897.
143. Dagher A, Owen AM, Boecker H, et al. The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease. Brain 2001; 124(5):1020-1032.
144. De Bie RM, Schuurman PR, Bosch DA, et al. Outcome of unilateral pallidotomy in advanced Parkinson's disease: cohort study of 32 patients. J Neurol Neurosurg Psychiatry 2001; 71(3): 375-382.
145. Woods SP, Fields JA, Tröster AI. Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a critical review. Neuropsych Rev 2002:111-126.
146. Galvez-Jimenez N, Lozano AM, Duff J, et al. Bilateral pallidotomy pronounced amelioration of incapacitating levodopa-induced dyskinesias but accompanying cognitive decline. Mov Disord 1996; 11: 242.
147. Lhermitte F. 'Utilization behaviour' and its relation to lesions of the frontal lobes. Brain 1983; 106(2): 237-255.
148. Lhermitte F, Pillon B, Serdaru M. Human autonomy and the frontal lobes. Part I: Imitation and utilization behavior: a neuropsychological study of 75 patients. Ann Neurol 1986; 19(4): 326-334.
149. Lhermitte F. Human autonomy and the frontal lobes. Part II: Patient behavior in complex and social situations: the "environmental dependency syndrome". Ann Neurol 1986; 19(4): 335-343.
150. Parkin SG, Gregory RP, Scott R, et al. Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: a case series of 115 patients. Mov Disord 2002; 17(4): 682-692.
151. Gross RE, Lombardi WJ, Lang AE, et al. Variability in lesion location following microelectrode-guided pallidotomy. II. Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's disease. Brain 1999;122 (Pt 3): 405-416.
152. Lombardi WJ, Gross RE, Trépanier LL, et al. Relationship of lesion location to cognitive outcome following microelectrodeguided pallidotomy for Parkinson's disease: support for the existence of cognitive circuits in the human pallidum. Brain 2000; 123: 746-758.
153. Dujardin K, Krystkowiak P, Defebvre L, Blond S, Destee A. A case of severe dysexecutive syndrome consecutive to chronic bilateral pallidal stimulation. Neuropsychologia 2000; 38: 1305-1315.
154. Ardouin C, Pillon B, Peiffer E, et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999; 46: 217-223.
155. Fields JA, Tröster AI, Wilkinson SB, et al. Cognitive outcome following staged bilateral pallidal stimulation for the treatment of Parkinson's disease. Clin Neurol Neurosurg 1999; 101: 182-188.
156. Bejjani B, Damier P, Arnulf I, et al. Pallidal stimulation for Parkinson's disease. Two targets? Neurology 1997; 49(6): 1564-1569.
157. Krack P, Pollak P, Limousin P, et al. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. Brain 1999; 122(6): 1133-1146.
158. Ashby P, Strafella A, Dostrovsky JO, Lozano A, Lang AE. Immediate motor effects of stimulation through electrodes implanted in the human globus pallidus. Stereotact Funct Neurosurg 1998; 70(1): 1-18.
159. Bejjani BP, Arnulf I, Houeto JL, et al. Concurrent excitatory and inhibitory effects of high frequency stimulation: an oculomotor study. J Neurol Neurosurg Psychiatry 2002; 72(4): 517-522.
160. Benazzouz A, Hallett M. Mechanism of action of deep brain stimulation. Neurology 2000; 55(12 Suppl 6): S13-S16.
161. Brown RG, Dowsey PL, Brown P, et al. Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease. Ann Neurol 1999; 45(4): 473-488.
162. Jahanshahi M, Ardouin CMA, Brown RG, et al. The impact of deep brain stimulation on executive function in Parkinson's disease. Brain 2000; 123(6): 1142-1154.
163. Pillon B, Ardouin C, Damier P, et al. Neuropsychological changes between "off" and "on" STN and GPi stimulation in Parkinson's disease. Neurology 2000; 55(3): 411-418.
164. Limousin P, Greene J, Pollak P, et al. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol 1997; 42(3): 283-291.
165. Carbon M, Eidelberg D. Modulation of regional brain function by deep brain stimulation: studies with positron emission tomography. Curr Opin Neurol 2002; 15(4): 451-455.
166. Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high frequency deep brain stimulation. N Engl J Med 1999; 340: 1476-1480.
167. Stefurak TL, Mikulis D, Mayberg H, et al. Deep brain stimulation associated dysphoria and cortico-limbic changes detected by fMRI. Mov Disord 2001; 16(Suppl. 1): S54-S55.
168. Krack P, Kumar R, Ardouin C, et al. Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord 2001; 16: 867-875.
169. Bejjani BP, Damier P, Arnulf I, et al. Deep brain stimulation in Parkinson's disease: opposite effects of stimulation in the pallidum. Mov Disord 1998; 13(6): 969-970.
170. Yelnik J, Damier P, Bejjani BP, et al. Functional mapping of the human globus pallidus: contrasting effect of stimulation in the internal and external pallidum in Parkinson's disease. Neuroscience 2000; 101(1): 77-87.
171. Heindel WC, Salmon DP, Shults CW, Walicke PA, Butters N. Neuropsychological evidence for multiple memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients. J Neurosci 1989; 9: 582-587.
172. Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. Progress Neurobiol 1996;50:381-425.
173. Wise SP, Murray EA, Gerfen CR. The frontal cortex-basal ganglia system in primates. Crit Rev Neurobiol 1996; 10(3-4): 317-356.
174. Filion M, Tremblay L, Matsumura M, Richard H. Focalisation dynamique de la convergence informationnelle dans les noyaux gris centraux. Rev Neurol (Paris) 1994; 150(8-9): 627-633.
175. Knowlton BJ, Mangels JA, Squire LR. A neostriatal habit learning system in humans. Science 1996; 273: 1399-1402.
176. Davis KD, Taub E, Houser D, et al. Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nat Med 1997; 3: 671-674.
177. Ceballos-Baumann A, Boecker H, Bartenstein P, et al. A positron emission tomography study of subthalamic nucleus stimulation in Parkinson's disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol 1999; 56: 997-1003.
178. Rezai AR, Lozano AM, Crawley AP, et al. Thalamic stimulation and functional magnetic resonance imaging: localization of cortical and subcortical activation with implanted electrodes. Technical note. J Neurosurg 1999; 90(3): 583-590.
179. Fukuda M, Edwards C, Eidelberg D. Functional brain networks in Parkinson's disease. Parkinsonism Relat Disord 2001; 8(2): 91-94.
180. 15O PET study. Brain 1997; 120: 1301-1313.
181. Sestini S, Scotto di Luzio A, Ammannati F, et al. Changes in regional cerebral blood flow caused by deep brain stimulation of the subthalamic nucleus in Parkinson's disease. J Nucl Med 2002; 43(6): 725-732.
182. Schubert T, Volkmann J, Muller U, et al. Effects of pallidal deep brain stimulation and levodopa treatment on reaction-time performance in Parkinson's disease. Exp Brain Res 2002; 144(1): 8-16.
183. Schroeder U, Kuehler A, Haslinger B, et al. Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain 2002; 125(9): 1995-2004.
184. Pollo A, Torre E, Lopiano L, et al. Expectation modulates the response to subthalamic nucleus stimulation in parkinsonian patients. Neuroreport 2002; 13(11): 1383-1386.
185. de la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 2001; 293(5532): 1164-1166.
186. Saint-Cyr JA, Hoque T, Pereira LCM, et al. The MRI localization of clinically effective stimulating electrodes in the human subthalamic nucleus. J Neurosurg 2002; 97: 1152-1166.
187. Lanotte MM, Rizzone M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry 2002; 72(1): 53-58.
188. Starr PA, Christine CW, Theodosopoulos PV, et al. Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg 2002; 97(2): 370-387.
189. Parent A, Cicchetti F. The current model of basal ganglia organization under scrutiny. Mov Disord 1998; 13(2): 199-202.
190. Parent A, Levesque M, Parent A. A re-evaluation of the current model of the basal ganglia. Parkinsonism Relat Disord 2001; 7(3): 193-198.